Fortress Biotech, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Fortress Biotech, Inc. stock issued during period, value, issued for services for the quarter ending 2020-09-30 was $18.00K.
- Fortress Biotech, Inc. stock issued during period, value, issued for services for the quarter ending 2018-12-31 was $498.00K.
- Fortress Biotech, Inc. stock issued during period, value, issued for services for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Fortress Biotech, Inc. stock issued during period, value, issued for services for the quarter ending 2018-06-30 was $1.00K.
- Fortress Biotech, Inc. stock issued during period, value, issued for services for fiscal 2019 was $500.00K, a 0.00% change from fiscal 2018.
- Fortress Biotech, Inc. stock issued during period, value, issued for services for fiscal 2018 was $500.00K.
- Fortress Biotech, Inc. stock issued during period, value, issued for services for fiscal 2016 was $2.00K, a 100.00% increase from fiscal 2015.
- Fortress Biotech, Inc. stock issued during period, value, issued for services for fiscal 2015 was $1.00K, a 75.00% decline from fiscal 2014.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2020-09-30 | $18.00K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $500.00K 10-K · filed 2020-03-16 | |
| 2018-12-31 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $500.00K 10-K · filed 2019-03-18 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | |
| 2018-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | |
| 2018-03-31 | $1.00K 10-Q · filed 2018-05-10 | |
| 2017-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $2.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $1.00K 10-Q · filed 2018-05-10 | $1.00K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $2.00K 10-K · filed 2017-03-16 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.00K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.00K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $2.00K 10-Q · filed 2017-05-10 | $2.00K derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $1.00K 10-Q · filed 2016-05-10 | $1.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $4.00K 10-K · filed 2017-03-16 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | |
| 2014-03-31 | $4.00K 10-Q · filed 2015-05-11 | |
| 2013-12-31 | $4.00K 10-K · filed 2016-03-15 | |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | |
| 2012-12-31 | $0.00 10-K · filed 2015-03-16 | |
| 2011-12-31 | $0.00 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |